Editorial: Editor's challenge: Dr. Luciano Mutti - what is the true impact of ICIs on survival in the treatment of thoracic malignancies?

Front Oncol. 2023 Sep 21:13:1285031. doi: 10.3389/fonc.2023.1285031. eCollection 2023.

Authors

Luciano Mutti^{1

2}, Steven G Gray³

Affiliations

¹ Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, PA, United States.
² Department of Applied Clinical Sciences and Biotechnology, L' Aquila University, L' Aquila, Italy.
³ Department of Clinical Medicine, Trinity St James's Cancer Institute, Trinity College Dublin, Dublin, Ireland.

No abstract available

Keywords: immune check inhibitor (ICI); malignancy; non-small cell lung cancer; survival; therapy.

Publication types

Editorial